SCHEMBL7069337

SCHEMBL7069337

O=C(O)c1cc(O)c(Cl)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
AKR1C2 P52895 3/20 0.44
AKR1C1 Q04828 3/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
AKR1C4 P17516 1/20 0.44
AKR1C3 P42330 1/20 0.44
PYGL P06737 2/20 0.43
MRGPRX4 Q96LA9 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ASPH Q12797 1/20 0.41
KDM8 Q8N371 1/20 0.41
TSHR P16473 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 3/20 0.41
TP53 P04637 1/20 0.41
CASP1 P29466 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18013115 0.92 KEAP1 (0.46) KEAP1NFE2L2AKR1C2AKR1C1CA1
SCHEMBL14331830 0.85 KEAP1 (0.50) KEAP1NFE2L2AKR1C2AKR1C1AKR1C4
SCHEMBL7842740 0.84 HPGD (0.38) KEAP1NFE2L2AKR1C2AKR1C1CA1
SCHEMBL23706639 0.83 PYGL (0.50) KEAP1NFE2L2AKR1C2AKR1C1CA1
SCHEMBL223134 0.83 KEAP1 (0.53) KEAP1NFE2L2AKR1C2AKR1C1AKR1C4
SCHEMBL22222257 0.82 KDM4E (0.47) KEAP1NFE2L2AKR1C2AKR1C1CA1
SCHEMBL30892458 0.82 KDM4E (0.47) KEAP1NFE2L2AKR1C2AKR1C1CA1
SCHEMBL9618645 0.82 HSP90AA1 (0.40) KDM4ETSHRHPGDHSD17B10ALDH1A1
SCHEMBL25297555 0.80 KDM4E (0.45) KEAP1NFE2L2AKR1C2AKR1C1CA1
SCHEMBL8279091 0.80 CA1 (0.57) AKR1C2AKR1C1CA1CA2AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055843-A1 AGARICOGLYCERIDES AND ANALOGS BAYER HEALTHCARE AG (DE) 2003-07-10 WO disclosed